246 related articles for article (PubMed ID: 37958291)
1. Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology.
Alghamdi S; Al-Hamoudi W
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958291
[TBL] [Abstract][Full Text] [Related]
2. Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View.
Abdelrahim M; Esmail A; Saharia A; Abudayyeh A; Abdel-Wahab N; Diab A; Murakami N; Kaseb AO; Chang JC; Gaber AO; Ghobrial RM
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406533
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors in liver transplant: a case series.
Rudolph M; Shah SA; Quillin R; Lemon K; Olowokure O; Latif T; Sohal D
J Gastrointest Oncol; 2023 Apr; 14(2):1141-1148. PubMed ID: 37201081
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy and transplantation for hepatocellular carcinoma.
Tabrizian P; Abdelrahim M; Schwartz M
J Hepatol; 2024 May; 80(5):822-825. PubMed ID: 38253289
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy before liver transplant in unresectable hepatocellular carcinoma: a case report.
Ohm H; Khwaja R; Karachiwala H
J Gastrointest Oncol; 2023 Dec; 14(6):2644-2649. PubMed ID: 38196545
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma: The Evolving Role of Systemic Therapies as a Bridging Treatment to Liver Transplantation.
Saleh Y; Abu Hejleh T; Abdelrahim M; Shamseddine A; Chehade L; Alawabdeh T; Mohamad I; Sammour M; Turfa R
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893200
[TBL] [Abstract][Full Text] [Related]
7. The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.
Ziogas IA; Evangeliou AP; Giannis D; Hayat MH; Mylonas KS; Tohme S; Geller DA; Elias N; Goyal L; Tsoulfas G
Oncologist; 2021 Jun; 26(6):e1036-e1049. PubMed ID: 33314549
[TBL] [Abstract][Full Text] [Related]
8. Trial watch: immunotherapeutic strategies on the horizon for hepatocellular carcinoma.
Koh B; Tan DJH; Lim WH; Wong JSL; Ng CH; Chan KE; Wang M; Yong WP; Dan YY; Wang LZ; Tan N; Muthiah M; Kow A; Syn NL; Huang DQ; Yau T
Oncoimmunology; 2023; 12(1):2214478. PubMed ID: 37284696
[TBL] [Abstract][Full Text] [Related]
9. Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy.
Dehghan Y; Schnickel GT; Hosseini M; Burgoyne AM; Ajmera VH; Morris GP; Mendler MH; Parekh JR; Abushamat F; Vodkin I; Kono Y
Clin J Gastroenterol; 2021 Dec; 14(6):1718-1724. PubMed ID: 34643885
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.
Katariya NN; Lizaola-Mayo BC; Chascsa DM; Giorgakis E; Aqel BA; Moss AA; Uson Junior PLS; Borad MJ; Mathur AK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565184
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art.
Laschtowitz A; Roderburg C; Tacke F; Mohr R
J Hepatocell Carcinoma; 2023; 10():181-191. PubMed ID: 36789252
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.
Luo Y; Teng F; Fu H; Ding GS
World J Gastrointest Oncol; 2022 Jan; 14(1):163-180. PubMed ID: 35116109
[TBL] [Abstract][Full Text] [Related]
13. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for transplantation of hepatocellular carcinoma: the next frontier in adjunctive therapy.
Tabrizian P; Zeitlhoefler M; Hassan AT; Marino R
Curr Opin Organ Transplant; 2024 Apr; 29(2):144-154. PubMed ID: 38164882
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
Jiang J; Huang H; Chen R; Lin Y; Ling Q
Front Immunol; 2023; 14():1092401. PubMed ID: 36875077
[TBL] [Abstract][Full Text] [Related]
16. Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.
Gao Q; Anwar IJ; Abraham N; Barbas AS
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944927
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy and Liver Transplantation: A Narrative Review of Basic and Clinical Data.
Wassmer CH; El Hajji S; Papazarkadas X; Compagnon P; Tabrizian P; Lacotte S; Toso C
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760542
[TBL] [Abstract][Full Text] [Related]
18. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant.
Anugwom CM; Leventhal TM; Debes JD
Hepatoma Res; 2022; 8():. PubMed ID: 35693455
[TBL] [Abstract][Full Text] [Related]
19. Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.
Gosalia AJ; Martin P; Jones PD
Gastroenterol Hepatol (N Y); 2017 Jul; 13(7):398-410. PubMed ID: 28867968
[TBL] [Abstract][Full Text] [Related]
20. When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road.
Gu Y; Xu S; Wang Z; Yang J; Zheng S; Wei Q; Liu Z; Xu X
Chin J Cancer Res; 2023 Apr; 35(2):92-107. PubMed ID: 37180832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
